These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 9092810)
1. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Robert M; Gibbs BF; Jacobson E; Gagnon C Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810 [TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin. Robert M; Gagnon C Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494 [TBL] [Abstract][Full Text] [Related]
3. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Jonsson M; Linse S; Frohm B; Lundwall A; Malm J Biochem J; 2005 Apr; 387(Pt 2):447-53. PubMed ID: 15563730 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody. Ménez R; Michel S; Muller BH; Bossus M; Ducancel F; Jolivet-Reynaud C; Stura EA J Mol Biol; 2008 Feb; 376(4):1021-33. PubMed ID: 18187150 [TBL] [Abstract][Full Text] [Related]
5. Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. Denmeade SR; Lou W; Lövgren J; Malm J; Lilja H; Isaacs JT Cancer Res; 1997 Nov; 57(21):4924-30. PubMed ID: 9354459 [TBL] [Abstract][Full Text] [Related]
6. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor. Malm J; Hellman J; Hogg P; Lilja H Prostate; 2000 Oct; 45(2):132-9. PubMed ID: 11027412 [TBL] [Abstract][Full Text] [Related]
7. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Iwamura M; Hellman J; Cockett AT; Lilja H; Gershagen S Urology; 1996 Aug; 48(2):317-25. PubMed ID: 8753751 [TBL] [Abstract][Full Text] [Related]
8. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. Deperthes D; Frenette G; Brillard-Bourdet M; Bourgeois L; Gauthier F; Tremblay RR; Dubé JY J Androl; 1996; 17(6):659-65. PubMed ID: 9016396 [TBL] [Abstract][Full Text] [Related]
9. Semenogelin, the main protein of the human semen coagulum, regulates sperm function. de Lamirande E Semin Thromb Hemost; 2007 Feb; 33(1):60-8. PubMed ID: 17253191 [TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization. Chen Z; Chen H; Stamey TA J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel semenogelin I-derived antimicrobial peptide from liquefied human seminal plasma. Zhao H; Lee WH; Shen JH; Li H; Zhang Y Peptides; 2008 Apr; 29(4):505-11. PubMed ID: 18314226 [TBL] [Abstract][Full Text] [Related]
12. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. Ohlsson K; Bjartell A; Lilja H J Androl; 1995; 16(1):64-74. PubMed ID: 7539415 [TBL] [Abstract][Full Text] [Related]
13. Ejaculates from the common marmoset (Callithrix jacchus) contain semenogelin and beta-microseminoprotein but not prostate-specific antigen. Valtonen-André C; Olsson AY; Nayudu PL; Lundwall A Mol Reprod Dev; 2005 Jun; 71(2):247-55. PubMed ID: 15791587 [TBL] [Abstract][Full Text] [Related]
14. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system. Suzuki K; Kise H; Nishioka J; Hayashi T Semin Thromb Hemost; 2007 Feb; 33(1):46-52. PubMed ID: 17253189 [TBL] [Abstract][Full Text] [Related]
15. Truncated semenogelin I binds zinc and is cleaved by prostate-specific antigen. Jonsson M; Lundwall A; Linse S; Frohm B; Malm J J Androl; 2006; 27(4):542-7. PubMed ID: 16582407 [TBL] [Abstract][Full Text] [Related]
16. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. Charlesworth MC; Young CY; Miller VM; Tindall DJ J Androl; 1999; 20(2):220-9. PubMed ID: 10232657 [TBL] [Abstract][Full Text] [Related]
17. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process. de Lamirande E; Yoshida K; Yoshiike TM; Iwamoto T; Gagnon C J Androl; 2001; 22(4):672-9. PubMed ID: 11451365 [TBL] [Abstract][Full Text] [Related]
18. Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen. Leinonen J; Wu P; Koivunen E; Närvänen A; Stenman UH Scand J Clin Lab Invest Suppl; 2000; 233():59-64. PubMed ID: 11317943 [TBL] [Abstract][Full Text] [Related]
19. Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation. Robert M; Gagnon C Int J Androl; 1994 Oct; 17(5):232-40. PubMed ID: 7698848 [TBL] [Abstract][Full Text] [Related]
20. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry. Bjartell A; Malm J; Moller C; Gunnarsson M; Lundwall A; H Lilja J Androl; 1996; 17(1):17-26. PubMed ID: 8833737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]